1. mrwhtwabbit
2. emielnl
3. codcoleu1ou0m4sl
4. ree222
5. dimespent
1.ree222 03/09/2018
Announces positive EU Approval for labelling update to Relvar Ellipta in patients with Asthma
2.mrwhtwabbit 02/07/2018
Going for the throat
3.dimespent 04/03/2018
US FDA accepts Biologics license application for moxetumomab pasudotox in hairy cell leukemia
4.codcoleu1ou0m4sl 01/25/2018
Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli…
5.emielnl 02/07/2018
GlaxoSmithKlines Bexsero receives Breakthrough Therapy Designation from FDA
6.mrwhtwabbit 02/07/2018
Good beat.
7.codcoleu1ou0m4sl 02/07/2018
Sees FY18 EPS of GBP1.15-1.19, excluding non-recurring items, vs. GBP1.06
8.mrwhtwabbit 02/15/2018
Receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months …
9.mrwhtwabbit 01/26/2018
Innoviva and GSK receives Positive Opinion from CHMP for labelling update to Relvar Ellipta in patients with …
10.codcoleu1ou0m4sl 03/05/2018
Presents positive results from OSMO study
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW